Rankings
▼
Calendar
ACLX Q1 2024 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena
ACLX
Arcellx, Inc.
$7B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$39M
+119.2% YoY
Gross Profit
$38M
97.9% margin
Operating Income
-$16M
-40.3% margin
Net Income
-$7M
-18.3% margin
EPS (Diluted)
$-0.14
QoQ Revenue Growth
-37.8%
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$38M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$780M
Total Liabilities
$283M
Stockholders' Equity
$497M
Cash & Equivalents
$155M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$39M
$18M
+119.2%
Gross Profit
$38M
$17M
+123.8%
Operating Income
-$16M
-$30M
+48.1%
Net Income
-$7M
-$27M
+73.7%
← FY 2024
All Quarters
Q2 2024 →